Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
The Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial demonstrated that Icosapent ethyl significantly reduced cardiovascular events compared to placebo.
This study examined pregnancy and post-delivery outcomes in women with type 1 diabetes using non-automated insulin pumps versus multiple daily injections. It found higher rates of preterm delivery and caesarean sections associated with insulin pumps.
This study analyzed the effects of Multifactorial Therapy (MT) versus Usual Care (UC) in participants with type 2 diabetes, finding significant reductions in major adverse cardiovascular events and all-cause mortality.
The study evaluated the addition of liraglutide to SGLT2 inhibitors and metformin in adults with type 2 diabetes, showing significant improvements in glycaemic control.
This randomized controlled trial evaluated the impact of a mobile health intervention on diabetes self-management, revealing significant improvements in foot care and dietary behaviors.
The StepAdd mobile health intervention aimed to improve physical activity in patients with Type 2 diabetes, resulting in significant increases in daily step counts.
This study compared the efficacy and safety of mulberry twig alkaloids (SZ-A) to canagliflozin in individuals with poorly controlled type 2 diabetes, finding both treatments effective in reducing key glucose metrics.
This study compared the effectiveness of nutritional therapy and alpha-glucosidase inhibitors in managing type 2 diabetes, finding significant reductions in glucose levels with both interventions.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
